Webinar

EU and China Clinical Requirements

How to leverage clinical investigation data for CE marking

Description

Join our expert-led webinar tailored for companies worldwide seeking to obtain or maintain the CE marking for medical devices in Europe. This session is designed to provide a comprehensive understanding of the clinical data requirements necessary to support successful CE marking submissions under current European regulations and the options and requirements when considering to collect this data in China.

This webinar is an essential resource for companies aiming to streamline their clinical data strategies, navigate cross-border regulatory requirements effectively, and optimize their pathways for achieving CE marking compliance.

Net price

Free of charge

Purpose of the webinar

Participants will get:

Overview of covered topics

Who should attend

Basic knowledge required

Presenting experts

Dr. Leslie Hammermüller

Senior Consultant
AKRA TEAM GmbH

Dr. Andrew Gibson

Team Leader - Senior Clinical Consultant
AKRA TEAM GmbH

Johnson Yang

Founder - CEO
Miracle Boost Limited (M&B)

Dr. Leslie Hammermüller

Senior Consultant
AKRA TEAM GmbH

Dr. Leslie Hammermueller is a senior consultant and project manager at AKRA TEAM GmbH. After graduating in human biology, she was a Clinical Data Manager for 10 years working on clinical studies in a global CRO before joining a medical device manufacturer as a Clinical Affairs Manager. In her current role at AKRA TEAM, she supports manufacturers of all device classes fulfilling the requirements of the EU — on the operational level as well as providing in-depth training — with a strong focus on clinical aspects.

Dr. Andrew Gibson

Team Leader - Senior Clinical Consultant
AKRA TEAM GmbH

Dr. Andrew Gibson is a senior consultant and team leader at AKRA TEAM GmbH. He is an experienced medical device regulatory affairs and quality management consultant. He has a background in microbiology, chemical characterization, and biotechnology. Working in Germany, Ireland and Canada, Andrew has had significant experience with EU, US, Canadian and other global regulations. Within these markets he has developed a unique skillset with a variety of medical devices from class I to class III. He has led project teams to identify gaps and update documentation helping manufacturers address the requirements of EU medical device regulation (MDR). He has specific expertise in clinical evaluation, post-market surveillance and technical documentation.

Johnson Yang

Founder - CEO
Miracle Boost Limited (M&B)

Mr. Johnson Yang, founder and CEO at Miracle Boost Limited (M&B). M&B is committed to providing full life cycle services for medical device manufactures in the pan-vascular field from China to go global. Main service includes regulatory registration, clinical and technical support, commercialization and so on. Mr. Yang has more than 20 years of management experience in the field of medical devices. Prior to founding M&B, Mr. Yang was the first marketing and sales manager at Edwards Lifesciences in China for THV business. During his service with Venus Medtech, he established China and international sales and marketing functions. During his time with Percutek Therapeutics, Mr. Yang served as director of international business.

Stephanie Schwenke

Senior Project Manager
Use-Lab GmbH

Dr. Anna Spehl

Senior Consultant
AKRA TEAM GmbH

Dr. Anna Spehl

Senior Consultant
AKRA TEAM GmbH

More upcoming trainings and webinars

Support & Training

You have not found the right training for you and you would be interested in an offer for a specific and customized training on another topic in the field of regulatory affairs? Or you are interested in support and hands on implementation services?

Scroll to Top

SUBSCRIBE

Sign up to our monthly publication 
EU MDR & IVDR Insider!

GDPR Cookie Consent with Real Cookie Banner